RevistaLab
While not true of all markets, the top 3 clusters have recently faced deteriorating employment. The chart below shows the year-over-year change in employment across the private sector overall and scientific R&D . . .
After several tough years marked by oversupply and slower demand, life science real estate has been searching for a bottom. Most major markets — from Boston to San Francisco and …
To understand each market, we have categorized life science buildings into four age groups. The markets with the most old buildings (built more than 40 years ago) are Chicago, New York and Philadelphia. This is . . .
Life Science real estate has been on a clip of fast expansion, fueled by the increased investor attention and heightened space demand the sector experienced in the wake of the …
What does ownership look like in smaller life science markets? In the chart below we have simplified ownership into either investor or user-owned. The top three markets are dominated by . . .
At the end of 2024, construction starts for life science projects had slowed to the lowest point since the onset of the pandemic, with less than 1 million square feet …
he Worcester Life Science market lies in Central Massachusetts (MA) and serves as a natural growth point for life science companies looking to grow from the Boston/Cambridge CBSA.
The 2Q25 transaction data is in and the first half of 2025 looked similar to the back half of 2024. Across the US, 68 life science properties, totaling 7.3 million square feet, have sold . . .
The US Life Science or Biotech real estate sector has seen tremendous growth during the past 3 years. Overall, since 2Q22, the US Life Science sector has grown by 17% to 401 million square feet (MSF) in 2Q25.
How have the core life science clusters held up with regards to life science employment? Employment is an important indicator of an industry’s health and gives a look into how the sector is handling the economic circumstances. The . . .
With many state-of-the-art, brand-new research facilities sitting empty across major research clusters in the U.S., established pharmaceutical and biotechnology firms have an opportunity to secure ideal spaces in prime locations. …
Over the past year a little over 10 million square feet of life science projects have broken ground. While that’s only a fourth of the peak in 2022, it still seems high considering the current gap between supply and demand. To understand . . .
20% of the life science space Revista tracks is pure manufacturing. Despite the oversupply of lab properties, the manufacturing sub section does not suffer the same issues. Manufacturing space is primarily driven by . . .
Last year Life Science inventory in the top 3 clusters, Boston, San Francisco & San Diego, grew by over 10%. With this incredible growth, combined with softer space demand, many …
Revista recently released data for the 1st quarter of 2025. The preliminary transaction data shows 14 life science properties traded hands during the quarter. As per the chart, 70 properties traded over . . .
After a record year of Life Science construction in 2024, early 2025 brings a much needed stall in new project deliveries. In 2024, 22.8 million square feet of Life Science …
Despite declining occupancy in 2024, it was a largely positive year on the demand side. 70% of the top 20 markets had positive absorption in 2024. Boston gained about 3.7 million in occupied space throughout . . .
With a significant amount of new inventory entering the market and weaker demand for space due to the volatile funding environment, the top three life science real estate markets—Boston, San …
How much has the life science real estate sector grown over the past decade? In the table below we are looking at growth from 2014-2024 for life science inventory & employment. The inventory growth is for all . . .
The Life Science Real Estate (LSRE) sector, like many other commercial real estate sectors, has seen transaction activity slow in recent years. Higher interest rates have created an uneasy investing and lending environment. The LSRE sector . . .
Preliminary data shows a total of $3.16 billion for life science sales in 2024, totaling 5.17 million square feet. This is equivalent to about half of the volume recorded in 2023. Yearly volume has maintained a consistent decline since 2022, and 2024 has yet to show a clear reversal. On a positive note, if . . .
The chart below shows aggregate LSRE trends in the top 3 markets from 2Q22 to 4Q24. It represents almost 150 million square feet tracked by RevistaLab.com in these 3 markets.